Sai Parenteral's, a company in the Pharmaceuticals industry, reported revenue of ₹195 crore and net profit of ₹11 crore for the September 2026 quarter.
Sai Parenteral's (NSE: SAIPARENT) closed at ₹492.30 on 20 Nov 2026. Its market capitalisation is ₹2,175 crore and it trades at 87.2 times earnings.
Incorporated in 2001, Sai Parenteral's Ltd. is a diversified pharmaceutical formulations company with expertise in research, development, and manufacturing.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.